Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Class A Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48.3M
-
Number of holders
-
164
-
Total 13F shares, excl. options
-
33.4M
-
Shares change
-
+1.22M
-
Total reported value, excl. options
-
$375M
-
Value change
-
+$29.8M
-
Put/Call ratio
-
0.31
-
Number of buys
-
78
-
Number of sells
-
-64
-
Price
-
$11.25
Significant Holders of Ginkgo Bioworks Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (DNA) as of Q2 2025
208 filings reported holding DNA - Ginkgo Bioworks Holdings, Inc. - Class A Common Stock, $0.0001 par value per share as of Q2 2025.
Ginkgo Bioworks Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (DNA) has 164 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.4M shares
of 48.3M outstanding shares and own 69.07% of the company stock.
Largest 10 shareholders include VIKING GLOBAL INVESTORS LP (3.58M shares), BAILLIE GIFFORD & CO (3.28M shares), BlackRock, Inc. (3.05M shares), VANGUARD GROUP INC (2.38M shares), Erste Asset Management GmbH (2M shares), Anchorage Capital Group, L.L.C. (1.75M shares), Legal & General Group Plc (1.49M shares), MILLENNIUM MANAGEMENT LLC (1.35M shares), BANK OF AMERICA CORP /DE/ (1.21M shares), and GOLDMAN SACHS GROUP INC (1.14M shares).
This table shows the top 164 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.